Matthew Schiffler is a senior research scientist at Eli Lilly and Company, a major pharmaceutical company, where he develops and applies computational and AI-driven methods to accelerate the drug discovery pipeline.
EDUCATION
Graduate Studies
Harvard University
Chemistry
Graduate Thesis
Total Synthesis of Membrenones A-C, Dynamic Kinetic Hetero-Diels-Alder Cycloaddition, and Progress Toward a Total Synthesis of Peloruside A
Undergraduate Studies
University of Virginia
IMPACT STORY
Lorem ipsum dolor sit amet, consecteta aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in.ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in.
READ MOREGET IN TOUCH WITH Matthew Schiffler
Lorem ipsum dolor sit amet, consecteta aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in.ur adipiscing elit,
